Key facts
- It has raised $137.9M; the latest was Early Stage VC ($137.9M) in Mar 2025.
- Notable investors include Beijing State-owned Capital Operation and Management, Beishang Capital Management (Beijing), CBC Group (Singapore).
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for EverBridge Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for EverBridge Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EverBridge Medical
Developer of medical technology focusing on peripheral vascular, neuroscience and tumor diagnosis and treatment. The company's solutions are innovative medical devices, providing clients with local treatment of high-incidence chronic diseases.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2021
- Website
- everbridgemed.com/
- Ownership
- Privately Held (backing)
EverBridge Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EverBridge Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EverBridge Medical in its N-PORT filings yet. We sweep new filings monthly.